Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Li Watsek's Stock Ratings
Cantor Fitzgerald Analyst
Li Watsek is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
-10.9%
Smart Score
Overall Average Return Percentile
17th
Number of Ratings
101
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/03/2025 | CMPX | Buy Now | Compass Therapeutics | $5.07 | — | — | Initiates | → Overweight | Get Alert | |
| 10/13/2025 | ASND | Buy Now | Ascendis Pharma | $213.24 | 19.11% | $203 → $254 | Maintains | Overweight | Get Alert | |
| 10/02/2025 | CNTX | Buy Now | Context Therapeutics | $1.13 | — | — | Initiates | → Overweight | Get Alert | |
| 09/09/2025 | IDYA | Buy Now | IDEAYA Biosciences | $33.37 | — | — | Reiterates | Overweight → Overweight | Get Alert | |
| 08/08/2025 | ASND | Buy Now | Ascendis Pharma | $213.24 | -4.8% | $200 → $203 | Maintains | Overweight | Get Alert | |
| 07/30/2025 | REPL | Buy Now | Replimune Group | $10.14 | — | — | Upgrade | Neutral → Overweight | Get Alert | |
| 06/26/2025 | KURA | Buy Now | Kura Oncology | $10.62 | — | — | Reiterates | Overweight → Overweight | Get Alert | |
| 06/20/2025 | REPL | Buy Now | Replimune Group | $10.14 | — | — | Initiates | → Overweight | Get Alert | |
| 05/12/2025 | ASND | Buy Now | Ascendis Pharma | $213.24 | -6.21% | $200 → $200 | Reiterates | Overweight → Overweight | Get Alert | |
| 03/27/2025 | ZLAB | Buy Now | Zai Lab | $17.35 | — | — | Reiterates | Overweight → Overweight | Get Alert | |
| 03/26/2025 | ACRV | Buy Now | Acrivon Therapeutics | $2.57 | — | — | Reiterates | Overweight → Overweight | Get Alert | |
| 03/14/2025 | TARA | Buy Now | Protara Therapeutics | $5.75 | — | — | Initiates | → Overweight | Get Alert | |
| 02/25/2025 | ASND | Buy Now | Ascendis Pharma | $213.24 | -6.21% | $170 → $200 | Maintains | Overweight | Get Alert | |
| 02/11/2025 | ASND | Buy Now | Ascendis Pharma | $213.24 | -20.28% | $170 → $170 | Reiterates | Overweight → Overweight | Get Alert | |
| 02/07/2025 | ARVN | Buy Now | Arvinas | $12.26 | — | — | Reiterates | Overweight → Overweight | Get Alert | |
| 01/31/2025 | ACRV | Buy Now | Acrivon Therapeutics | $2.57 | — | — | Initiates | → Overweight | Get Alert | |
| 01/24/2025 | ALXO | Buy Now | ALX Oncology Holdings | $1.38 | — | — | Reiterates | Overweight → Overweight | Get Alert | |
| 01/13/2025 | IDYA | Buy Now | IDEAYA Biosciences | $33.37 | — | — | Reiterates | Overweight → Overweight | Get Alert | |
| 12/18/2024 | ALXO | Buy Now | ALX Oncology Holdings | $1.38 | — | — | Reiterates | Overweight → Overweight | Get Alert | |
| 12/17/2024 | IDYA | Buy Now | IDEAYA Biosciences | $33.37 | — | — | Reiterates | Overweight → Overweight | Get Alert | |
| 12/09/2024 | KURA | Buy Now | Kura Oncology | $10.62 | — | — | Reiterates | Overweight → Overweight | Get Alert | |
| 11/26/2024 | KURA | Buy Now | Kura Oncology | $10.62 | — | — | Reiterates | → Overweight | Get Alert | |
| 11/21/2024 | KURA | Buy Now | Kura Oncology | $10.62 | — | — | Reiterates | → Overweight | Get Alert | |
| 11/19/2024 | AFMD | Buy Now | Affimed | — | — | — | Reiterates | → Overweight | Get Alert | |
| 11/15/2024 | ASND | Buy Now | Ascendis Pharma | $213.24 | -20.28% | $170 → $170 | Reiterates | Overweight → Overweight | Get Alert | |
| 11/12/2024 | ALXO | Buy Now | ALX Oncology Holdings | $1.38 | — | — | Reiterates | → Overweight | Get Alert | |
| 11/06/2024 | KURA | Buy Now | Kura Oncology | $10.62 | — | — | Reiterates | → Overweight | Get Alert | |
| 11/04/2024 | ASND | Buy Now | Ascendis Pharma | $213.24 | -20.28% | $170 → $170 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/07/2024 | RCUS | Buy Now | Arcus Biosciences | $21.69 | — | — | Reiterates | → Overweight | Get Alert | |
| 10/03/2024 | RCUS | Buy Now | Arcus Biosciences | $21.69 | — | — | Reiterates | → Overweight | Get Alert | |
| 09/16/2024 | ASND | Buy Now | Ascendis Pharma | $213.24 | -20.28% | $170 → $170 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/09/2024 | KURA | Buy Now | Kura Oncology | $10.62 | — | — | Reiterates | → Overweight | Get Alert | |
| 09/09/2024 | ARVN | Buy Now | Arvinas | $12.26 | — | — | Reiterates | → Overweight | Get Alert | |
| 09/09/2024 | AFMD | Buy Now | Affimed | — | — | — | Reiterates | → Overweight | Get Alert | |
| 09/09/2024 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | $20 → $20 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/09/2024 | ASND | Buy Now | Ascendis Pharma | $213.24 | -20.28% | $170 → $170 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/09/2024 | BCYC | Buy Now | Bicycle Therapeutics | $7.40 | — | — | Reiterates | → Overweight | Get Alert | |
| 09/04/2024 | ASND | Buy Now | Ascendis Pharma | $213.24 | -20.28% | $173 → $170 | Maintains | Overweight | Get Alert | |
| 08/16/2024 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | → $20 | Initiates | → Overweight | Get Alert | |
| 08/12/2024 | ALXO | Buy Now | ALX Oncology Holdings | $1.38 | — | — | Reiterates | → Overweight | Get Alert | |
| 08/09/2024 | KURA | Buy Now | Kura Oncology | $10.62 | — | — | Reiterates | → Overweight | Get Alert | |
| 08/09/2024 | RCUS | Buy Now | Arcus Biosciences | $21.69 | — | — | Reiterates | → Overweight | Get Alert | |
| 07/31/2024 | ARVN | Buy Now | Arvinas | $12.26 | — | — | Reiterates | → Overweight | Get Alert | |
| 05/29/2024 | ALXO | Buy Now | ALX Oncology Holdings | $1.38 | — | — | Reiterates | → Overweight | Get Alert | |
| 05/15/2024 | ASND | Buy Now | Ascendis Pharma | $213.24 | -18.87% | $173 → $173 | Reiterates | Overweight → Overweight | Get Alert | |
| 05/15/2024 | CRIS | Buy Now | Curis | $1.21 | — | — | Reiterates | → Overweight | Get Alert | |
| 05/03/2024 | ASND | Buy Now | Ascendis Pharma | $213.24 | -18.87% | → $173 | Reiterates | Overweight → Overweight | Get Alert | |
| 04/18/2024 | ASND | Buy Now | Ascendis Pharma | $213.24 | -18.87% | $173 → $173 | Reiterates | Overweight → Overweight | Get Alert | |
| 04/12/2024 | ALXO | Buy Now | ALX Oncology Holdings | $1.38 | — | — | Reiterates | → Overweight | Get Alert | |
| 04/09/2024 | VINC | Buy Now | Vincerx Pharma | $0.01 | — | — | Reiterates | → Overweight | Get Alert | |
| 04/01/2024 | ASND | Buy Now | Ascendis Pharma | $213.24 | -18.87% | $173 → $173 | Reiterates | Overweight → Overweight | Get Alert | |
| 04/01/2024 | VINC | Buy Now | Vincerx Pharma | $0.01 | — | — | Reiterates | → Overweight | Get Alert | |
| 04/01/2024 | CRVS | Buy Now | Corvus Pharma | $8.26 | — | — | Reiterates | → Overweight | Get Alert | |
| 04/01/2024 | AFMD | Buy Now | Affimed | — | — | — | Reiterates | → Overweight | Get Alert | |
| 02/06/2024 | ASND | Buy Now | Ascendis Pharma | $213.24 | -18.87% | $152 → $173 | Maintains | Overweight | Get Alert | |
| 12/20/2023 | ASND | Buy Now | Ascendis Pharma | $213.24 | -28.72% | → $152 | Reiterates | Overweight → Overweight | Get Alert | |
| 11/22/2023 | SLS | Buy Now | SELLAS Life Sciences Gr | $2.06 | 45.63% | → $3 | Reiterates | Overweight → Overweight | Get Alert | |
| 11/08/2023 | RCUS | Buy Now | Arcus Biosciences | $21.69 | 65.98% | $46 → $36 | Maintains | Overweight | Get Alert | |
| 11/08/2023 | BCYC | Buy Now | Bicycle Therapeutics | $7.40 | 778.38% | → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/04/2023 | ALXO | Buy Now | ALX Oncology Holdings | $1.38 | 1566.67% | $18 → $23 | Maintains | Overweight | Get Alert | |
| 09/25/2023 | AFMD | Buy Now | Affimed | — | — | → $7 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/15/2023 | ASND | Buy Now | Ascendis Pharma | $213.24 | -28.72% | → $152 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/12/2023 | BCYC | Buy Now | Bicycle Therapeutics | $7.40 | 778.38% | → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/12/2023 | AFMD | Buy Now | Affimed | — | — | → $7 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/07/2023 | ARVN | Buy Now | Arvinas | $12.26 | 470.96% | $70 → $70 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/07/2023 | VINC | Buy Now | Vincerx Pharma | $0.01 | 97939.22% | → $5 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/07/2023 | SLS | Buy Now | SELLAS Life Sciences Gr | $2.06 | 45.63% | → $3 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/07/2023 | PRTG | Buy Now | Portage Biotech | — | — | → $11 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/07/2023 | ONCT | Buy Now | Oncternal Therapeutics | — | — | → $1.3 | Reiterates | Neutral → Neutral | Get Alert | |
| 09/07/2023 | KURA | Buy Now | Kura Oncology | $10.62 | 182.49% | → $30 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/07/2023 | FATE | Buy Now | Fate Therapeutics | $1.10 | 354.55% | → $5 | Reiterates | Neutral → Neutral | Get Alert | |
| 09/07/2023 | CRVS | Buy Now | Corvus Pharma | $8.26 | -51.57% | → $4 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/07/2023 | BCYC | Buy Now | Bicycle Therapeutics | $7.40 | 778.38% | → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/07/2023 | ASND | Buy Now | Ascendis Pharma | $213.24 | -28.72% | → $152 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/07/2023 | APTO | Buy Now | Aptose Biosciences | — | — | → $38 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/07/2023 | AFMD | Buy Now | Affimed | — | — | → $7 | Reiterates | Overweight → Overweight | Get Alert | |
| 08/31/2023 | PRTG | Buy Now | Portage Biotech | — | — | → $11 | Reiterates | Overweight → Overweight | Get Alert | |
| 08/01/2023 | PRTG | Buy Now | Portage Biotech | — | — | $16 → $11 | Maintains | Overweight | Get Alert | |
| 07/21/2023 | KURA | Buy Now | Kura Oncology | $10.62 | 182.49% | → $30 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/13/2023 | KURA | Buy Now | Kura Oncology | $10.62 | 182.49% | → $30 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/12/2023 | APTO | Buy Now | Aptose Biosciences | — | — | $6 → $38 | Maintains | Overweight | Get Alert | |
| 06/01/2023 | ASND | Buy Now | Ascendis Pharma | $213.24 | -28.72% | → $152 | Reiterates | Overweight → Overweight | Get Alert | |
| 05/09/2023 | CRVS | Buy Now | Corvus Pharma | $8.26 | -51.57% | $2 → $4 | Maintains | Overweight | Get Alert | |
| 05/04/2023 | FATE | Buy Now | Fate Therapeutics | $1.10 | 354.55% | $8 → $5 | Maintains | Neutral | Get Alert | |
| 04/28/2023 | ASND | Buy Now | Ascendis Pharma | $213.24 | -28.72% | $142 → $152 | Maintains | Overweight | Get Alert | |
| 04/04/2023 | ONCT | Buy Now | Oncternal Therapeutics | — | — | $4 → $1.3 | Maintains | Overweight | Get Alert | |
| 02/27/2023 | BCYC | Buy Now | Bicycle Therapeutics | $7.40 | 900% | → $74 | Reiterates | → Overweight | Get Alert | |
| 01/31/2023 | ARVN | Buy Now | Arvinas | $12.26 | 634.09% | $90 → $90 | Reiterates | Overweight → Overweight | Get Alert | |
| 12/22/2022 | ONCT | Buy Now | Oncternal Therapeutics | — | — | → $4 | Initiates | → Overweight | Get Alert | |
| 11/04/2022 | FATE | Buy Now | Fate Therapeutics | $1.10 | 3990.91% | $98 → $45 | Assumes | → Overweight | Get Alert | |
| 08/12/2022 | NKTX | Buy Now | Nkarta | $1.84 | 1965.22% | $60 → $38 | Maintains | Overweight | Get Alert | |
| 08/09/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | $75 → $68.5 | Downgrade | Overweight → Neutral | Get Alert | |
| 07/12/2022 | KURA | Buy Now | Kura Oncology | $10.62 | 182.49% | → $30 | Initiates | → Overweight | Get Alert | |
| 06/28/2022 | SLS | Buy Now | SELLAS Life Sciences Gr | $2.06 | 191.26% | $10 → $6 | Maintains | Overweight | Get Alert | |
| 06/08/2022 | VINC | Buy Now | Vincerx Pharma | $0.01 | 156762.75% | $22 → $8 | Maintains | Overweight | Get Alert | |
| 02/23/2022 | AFMD | Buy Now | Affimed | — | — | → $12 | Initiates | → Overweight | Get Alert | |
| 12/23/2021 | VINC | Buy Now | Vincerx Pharma | $0.01 | 490096.08% | → $25 | Initiates | → Overweight | Get Alert | |
| 12/03/2021 | CRVS | Buy Now | Corvus Pharma | $8.26 | -3.15% | $5 → $8 | Maintains | Overweight | Get Alert | |
| 07/21/2021 | SLS | Buy Now | SELLAS Life Sciences Gr | $2.06 | 773.79% | → $18 | Initiates | → Overweight | Get Alert | |
| 05/27/2021 | CRVS | Buy Now | Corvus Pharma | $8.26 | 21.07% | → $10 | Initiates | → Overweight | Get Alert | |
| 11/25/2019 | GBT | Buy Now | Global Blood Therapeutics | — | — | $110 → $98 | Maintains | Overweight | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved